Form 8-K - Current report:
SEC Accession No. 0001723128-24-000037
Filing Date
2024-11-08
Accepted
2024-11-08 06:08:39
Documents
3
Period of Report
2024-09-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amrx-q32024x8k.htm 8-K 26945
2 EX-99.1 amrx-q32024ex991.htm EX-99.1 503626
3 amneala.jpg GRAPHIC 2670
  Complete submission text file 0001723128-24-000037.txt   535564
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38485 | Film No.: 241437848
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)